医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Lymphoblastic (diffuse) non-Hodgkin lymphoma (C83.500) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being
Plasmablastic lymphoma (C83.402) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Immunoblastic sarcoma (C83.401) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Immunoblastic (diffuse) non-Hodgkin lymphoma (C83.400) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being
Malignant lymphoma, large B-cell, diffuse, immunoblastic (C83.311) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduct
T-cell/histiocyte-rich large B-cell lymphoma (C83.310) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being
Thymic large B-cell lymphoma (C83.309) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Intravascular large B-cell lymphoma: numerous tumor B cells aggregate within vessels; preferentially involves CNS and skin.
肿瘤内科Mediastinal large B-cell lymphoma (C83.307) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Diffuse large B-cell lymphoma (C83.306) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Anaplastic large B-cell lymphoma (C83.305) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
T-cell-rich B-cell lymphoma (C83.304) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Malignant lymphoma, large-cell, non-cleaved (diffuse) (C83.303) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction
Malignant lymphoma, large-cell, cleaved (diffuse) (C83.302) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is
Primary reticulum-cell sarcoma of bone arises from marrow/cancellous bone; distinct from diffuse lymphoma-type reticulum-cell sarcoma; localized solitary bone lesion; 5% of primary bone malignancies. Age 20-30; M:F 2:1; femur/tibia/humerus; 1/3 around kne
肿瘤外科Diffuse large B-cell lymphoma associated with chronic inflammation (C83.300x009) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed patholog
EBV-positive diffuse large B-cell lymphoma of the elderly (C83.300x008) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological intr
Primary cutaneous diffuse large B-cell lymphoma (leg type) (C83.300x007) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological int
Primary CNS diffuse large B-cell lymphoma (C83.300x006) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is bein
Pleomorphic reticulum-cell sarcoma (C83.300x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compi
|
